Author

Eva E. Shrader

Observed name: Eva Shrader

Institution: Pancreatic Cancer Action Network

Observed institution: Pancreatic Cancer Action Network

ORCID: 0009-0005-8325-814X

Observed ORCID: 0009-0005-8325-814X

OpenAlex ID: A5011046280

Early Detection Initiative: A randomized controlled trial of algorithm-based screening in patients with new onset hyperglycemia and diabetes for early detection of pancreatic ductal adenocarcinoma

2021 · Suresh T. Chari, Anirban Maitra, et al. · Contemporary Clinical Trials · 67

Potential Cost-Effectiveness of Risk-Based Pancreatic Cancer Screening in Patients With New-Onset Diabetes

2021 · Naomi R.M. Schwartz, Lynn M. Matrisian, et al. · Journal of the National Comprehensive Cancer Network · 46

Identifying Symptoms Prior to Pancreatic Ductal Adenocarcinoma Diagnosis in Real-World Care Settings: Natural Language Processing Approach

2023 · Fagen Xie, Jenny Chang, et al. · JMIR AI · 9

Identifying signs and symptoms of pancreatic cancer: a population-based study using electronic health records and natural language processing

2025 · Wansu Chen, Fagen Xie, et al. · Pancreatology · 7

The potential cost-effectiveness of a risk-based pancreatic cancer screening strategy in new-onset diabetes.

2020 · Naomi RM Schwartz, Lynn McCormick Matrisian, et al. · Journal of Clinical Oncology · 3

Abstract A028: The Early Detection Initiative trial version 2: A platform trial to test novel approaches to pancreatic cancer screening in patients with new onset hyperglycemia and diabetes

2022 · Ying-Qi Zhao, Suresh T. Chari, et al. · Cancer Research

Works count: 6

Citation count: 132

H-index: 4

I10-index: 2